Article info

Download PDFPDF

Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice

Authors

  1. Correspondence to Dr Florentino Carral San Laureano, Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real 11510, Spain; florencarral{at}hotmail.com
View Full Text

Citation

Carral San Laureano F, Tomé Fernández-Ladreda M, Jiménez Millán AI, et al
Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice

Publication history

  • Accepted March 5, 2021
  • First published March 26, 2021.
Online issue publication 
June 01, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.